Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 22584792)

  • 1. Tumor markers in clinical practice: a review focusing on common solid cancers.
    Duffy MJ
    Med Princ Pract; 2013; 22(1):4-11. PubMed ID: 22584792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers in hemodialysis patients.
    Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
    [No Abstract]   [Full Text] [Related]  

  • 3. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
    Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
    Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
    Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
    Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular methods for the diagnosis of cancer.
    Cairns P; Sidransky D
    Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring.
    Bidart JM; Thuillier F; Augereau C; Chalas J; Daver A; Jacob N; Labrousse F; Voitot H
    Clin Chem; 1999 Oct; 45(10):1695-707. PubMed ID: 10508114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
    Bekci TT; Senol T; Maden E
    J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
    Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Biomarkers in Screening for Cancer.
    Duffy MJ
    Adv Exp Med Biol; 2015; 867():27-39. PubMed ID: 26530358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of tumor markers in patients with solid cancers: A critical review.
    Duffy MJ
    Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour markers with clinically controlled cut-offs for suspected cancer.
    Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A
    Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of serum tumor markers.
    Bates SE
    Ann Intern Med; 1991 Oct; 115(8):623-38. PubMed ID: 1716430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of cancer biomarkers in diabetic and non-diabetic proteinuric patients: a preliminary study.
    Turgutalp K; Ozhan O; Helvacı I; Ata A; Arican A; Boztepe B; Kıykım A
    Clin Chem Lab Med; 2013 Apr; 51(4):889-95. PubMed ID: 23314541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of serum tumor markers for the early diagnosis of neoplasm and in health exams for asymptomatic persons].
    Bernabé Caro R; Moreno Nogueira JA
    Rev Clin Esp; 2002 Apr; 202(4):212-4. PubMed ID: 12003731
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of tumor markers in gynecologic oncology.
    Olt G; Berchuck A; Bast RC
    Obstet Gynecol Surv; 1990 Sep; 45(9):570-7. PubMed ID: 1697940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.